3National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Susceptibility Testing,Twelfth Informational Supplement[S]. 2003 ,M100-S13. 被引量：1
4Jae-Hoon Song. Pneumococcal Resistance to Beta-Lactams and Macrolides[C]. International Symposium on Antimicrobial Agents and Resistance, 2003,30-33. 被引量：1
5Center for diseases prevention &epidemiology. oregon health division. Vancomycin-resistant enterococcal infections[J]. C D summary, 1997,46:1. 被引量：1
7Wang H, KelKar S, Wu W, etal, Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases:prevalence of CTX-M-3 at a hospital in China[J]. Antimicrob Agents chemother, 2003,47: 790-793. 被引量：1
8Chanawong A,MZali FH, Heritage J. et al. Three cefortaximases, CTX-M-9, CTX-M-13 and CTX-M-14, among Enterobacteriaceae in the People's Republic of China[J]. Antimicrob Agents Chemother, 2002,46: 630-637. 被引量：1
